293 related articles for article (PubMed ID: 34571878)
1. α-Synuclein Decreases the Abundance of Proteasome Subunits and Alters Ubiquitin Conjugates in Yeast.
Popova B; Galka D; Häffner N; Wang D; Schmitt K; Valerius O; Knop M; Braus GH
Cells; 2021 Aug; 10(9):. PubMed ID: 34571878
[TBL] [Abstract][Full Text] [Related]
2. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1.
Galka D; Ali TT; Bast A; Niederleithinger M; Gerhardt E; Motosugi R; Sakata E; Knop M; Outeiro TF; Popova B; Braus GH
Aging Cell; 2024 May; 23(5):e14128. PubMed ID: 38415292
[TBL] [Abstract][Full Text] [Related]
4. Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome.
Petroi D; Popova B; Taheri-Talesh N; Irniger S; Shahpasandzadeh H; Zweckstetter M; Outeiro TF; Braus GH
J Biol Chem; 2012 Aug; 287(33):27567-79. PubMed ID: 22722939
[TBL] [Abstract][Full Text] [Related]
5. The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.
Park HJ; Ryu D; Parmar M; Giasson BI; McFarland NR
PLoS One; 2017; 12(9):e0184262. PubMed ID: 28877262
[TBL] [Abstract][Full Text] [Related]
6. Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.
Popova B; Kleinknecht A; Braus GH
Biomolecules; 2015 Apr; 5(2):617-34. PubMed ID: 25915624
[TBL] [Abstract][Full Text] [Related]
7. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
[TBL] [Abstract][Full Text] [Related]
8. Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis.
Chau KY; Ching HL; Schapira AH; Cooper JM
J Neurochem; 2009 Aug; 110(3):1005-13. PubMed ID: 19493164
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation Protects Against β-Synuclein Toxicity in Yeast.
Popova B; Kleinknecht A; Arendarski P; Mischke J; Wang D; Braus GH
Front Mol Neurosci; 2018; 11():94. PubMed ID: 29636661
[TBL] [Abstract][Full Text] [Related]
10. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
Smith WW; Margolis RL; Li X; Troncoso JC; Lee MK; Dawson VL; Dawson TM; Iwatsubo T; Ross CA
J Neurosci; 2005 Jun; 25(23):5544-52. PubMed ID: 15944382
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.
Tenreiro S; Reimão-Pinto MM; Antas P; Rino J; Wawrzycka D; Macedo D; Rosado-Ramos R; Amen T; Waiss M; Magalhães F; Gomes A; Santos CN; Kaganovich D; Outeiro TF
PLoS Genet; 2014 May; 10(5):e1004302. PubMed ID: 24810576
[TBL] [Abstract][Full Text] [Related]
13. Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions.
Shahpasandzadeh H; Popova B; Kleinknecht A; Fraser PE; Outeiro TF; Braus GH
J Biol Chem; 2014 Nov; 289(45):31224-40. PubMed ID: 25231978
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of α-synuclein solubility in living cells using split GFP complementation.
Kothawala A; Kilpatrick K; Novoa JA; Segatori L
PLoS One; 2012; 7(8):e43505. PubMed ID: 22927976
[TBL] [Abstract][Full Text] [Related]
15. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
Stefanova N; Kaufmann WA; Humpel C; Poewe W; Wenning GK
Acta Neuropathol; 2012 Jul; 124(1):51-65. PubMed ID: 22491959
[TBL] [Abstract][Full Text] [Related]
16. Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context.
Sancenon V; Lee SA; Patrick C; Griffith J; Paulino A; Outeiro TF; Reggiori F; Masliah E; Muchowski PJ
Hum Mol Genet; 2012 Jun; 21(11):2432-49. PubMed ID: 22357655
[TBL] [Abstract][Full Text] [Related]
17. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.
Liu CW; Giasson BI; Lewis KA; Lee VM; Demartino GN; Thomas PJ
J Biol Chem; 2005 Jun; 280(24):22670-8. PubMed ID: 15840579
[TBL] [Abstract][Full Text] [Related]
18. A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology.
Gerez JA; Prymaczok NC; Rockenstein E; Herrmann US; Schwarz P; Adame A; Enchev RI; Courtheoux T; Boersema PJ; Riek R; Peter M; Aguzzi A; Masliah E; Picotti P
Sci Transl Med; 2019 Jun; 11(495):. PubMed ID: 31167929
[TBL] [Abstract][Full Text] [Related]
19. In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity.
Shamoto-Nagai M; Maruyama W; Hashizume Y; Yoshida M; Osawa T; Riederer P; Naoi M
J Neural Transm (Vienna); 2007; 114(12):1559-67. PubMed ID: 17690948
[TBL] [Abstract][Full Text] [Related]
20. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
